ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
eFFECTOR Therapeutics Inc (EM)

eFFECTOR Therapeutics Inc (EM) (EFTR)

0.0002
0.00
(0.00%)
終了 6月23日 5:00AM

eFFECTOR Therapeutics Inc (EM) (EFTR) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
0.0002
( - )
買値
0.00
売値
0.00
出来高
60
0.00 日の範囲 0.00
0.0002 52 週間の範囲 0.02
時価総額
前日終値
0.0002
始値
-
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
US$ 3,705
発行済株式数
4,704,409
配当利回り
PER
-0
1 株当たり利益 (EPS)
-12.41
歳入
-
純利益
-34.63M

eFFECTOR Therapeutics Inc (EM) について

eFFECTOR Therapeutics, Inc., a biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. The company’s lead product candidate includes Zotatifin, an inhibitor of eIF4A, which is in Phase 1/2 clinical trial to treat patients with ... eFFECTOR Therapeutics, Inc., a biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. The company’s lead product candidate includes Zotatifin, an inhibitor of eIF4A, which is in Phase 1/2 clinical trial to treat patients with solid tumors, as well as has completed Phase 2 clinical trial in combination with fulvestrant and abemaciclib to treat patients with ER+ breast cancer. It also develops Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. It has a research collaboration and license agreement with Pfizer Inc. to research and develop small molecules that target eIF4E. eFFECTOR Therapeutics, Inc. was founded in 2012 and is headquartered in Solana Beach, California. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Solana Beach, United States
設立
2026
eFFECTOR Therapeutics Inc (EM) is listed in the Healthcare sector of the その他OTC with ticker EFTR. The last closing price for eFFECTOR Therapeutics (EM) was US$0. Over the last year, eFFECTOR Therapeutics (EM) shares have traded in a share price range of US$ 0.0002 to US$ 0.02.

eFFECTOR Therapeutics (EM) currently has 4,704,409 shares in issue. The market capitalisation of eFFECTOR Therapeutics (EM) is US$940.88 . eFFECTOR Therapeutics (EM) has a price to earnings ratio (PE ratio) of -0.00.

EFTR 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1000.00020.00060.00025540.00027465CS
4000.00020.00060.000211270.00040589CS
12000.00020.00060.000235210.0004413CS
26000.00020.010.000254680.00028085CS
52000.00020.020.000246590.00036112CS
156-0.0998-99.80.10.171.0E-6259470.04913212CS
260-0.0998-99.80.10.171.0E-6259470.04913212CS

EFTR - Frequently Asked Questions (FAQ)

What is the current eFFECTOR Therapeutics Inc (EM) share price?
The current share price of eFFECTOR Therapeutics Inc (EM) is US$ 0.0002
How many eFFECTOR Therapeutics Inc (EM) shares are in issue?
eFFECTOR Therapeutics Inc (EM) has 4,704,409 shares in issue
What is the market cap of eFFECTOR Therapeutics Inc (EM)?
The market capitalisation of eFFECTOR Therapeutics Inc (EM) is USD 940.88
What is the 1 year trading range for eFFECTOR Therapeutics Inc (EM) share price?
eFFECTOR Therapeutics Inc (EM) has traded in the range of US$ 0.0002 to US$ 0.02 during the past year
What is the PE ratio of eFFECTOR Therapeutics Inc (EM)?
The price to earnings ratio of eFFECTOR Therapeutics Inc (EM) is -0
What is the registered address of eFFECTOR Therapeutics Inc (EM)?
The registered address for eFFECTOR Therapeutics Inc (EM) is 142 North Cedros Avenue, Solana Beach, California, 92075
What is the eFFECTOR Therapeutics Inc (EM) website address?
The website address for eFFECTOR Therapeutics Inc (EM) is effector.com
Which industry sector does eFFECTOR Therapeutics Inc (EM) operate in?
eFFECTOR Therapeutics Inc (EM) operates in the Biotechnology & Life Sciences sector

EFTR 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock